A new study from the Netherlands (published in the May 31, 2012 issue of the New England Journal of Medicine) indicates that patients afflicted with esophagus cancer exhibit a greater chance of survival when administered chemotherapy and radiation before surgery. The study further states that "patients in the chemo-radiation group lived an average of about 4 years, compared to about 2 years in the patients who got surgery alone." The purpose of this treatment is to attempt to shrink the cancer and thus make it easier to remove.
To read more about this study, click here.
Study mentioned: van Hagen P et al. Preoprtative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012 May 31; 366(22):2074-84. PMID 22646630
No comments:
Post a Comment